- Home
- Public Health Emergency Updates for CAP Customers
- COVID-19 Topic Center
- COVID-19 Topic Center Listing
Policy and Advocacy
-  CAP Survey of Accredited Laboratories Confirms COVID-19 Testing Challenges
 Laboratory directors share information on COVID-19 testing and key barriers to expanding testing.
- Answers to Your Questions About Small Business Assistance During COVID-19
 Resources to help ease the burden you face during the COVID-19 pandemic.
- COVID-19 Advocacy FAQs
 FAQs that summarize regulatory and payment issues affecting pathologists during the COVID-19 pandemic.
Microbiology
- Testing for COVID-19 Variants
 CAP Microbiology Committee addresses testing for COVID-19 variants.
- Learn more about Cycle Threshold (Ct) Values
 CAP Microbiology Committee offers questions and answers on Ct values.
- Caution Must Be Used in Interpreting the Cycle Threshold (Ct) Value
 Read the CAP Microbiology Committee’s letter to the editor in Clinical Infectious Diseases.
- The ABCs of Rapid Antigen Testing for Consumers
 The CAP’s Microbiology Committee addresses rapid antigen testing for the public.
- At-home tests and COVID-19 
 CAP clarifies at-home testing.
- Antigen Proficiency Testing for SARS-CoV-2 Virus
 Listen to this CAPcast about SARS-CoV-2 antigen PT.
- Quality Cross Check SARS-CoV-2 Testing
 Hear this CAPcast to help you manage instrumentation for SARS-CoV-2 testing.
- Screening and Surveillance Guidance 
 Breaking down the differences between screening and surveillance.
- Guidance on Pooled Testing
 Considerations on the pros and cons of pooled testing.
- CAP Statement on the Current Role of Serologic Testing for SARS-CoV-2
 Guidance on best use of serology testing.
- CAP introduces SARS-CoV-2 proficiency testing (PT) programs
 New PT programs to support laboratories quality control efforts.
- Using Proficiency Testing to Ensure Accurate SARS-CoV-2 Testing
 A CAPcast addressing a new PT program for the detection of SARS-CoV-2 by nucleic acid amplification testing.
- Microbiology Committee Perspective: Caution must be used in interpreting the Cycle Threshold (Ct) value
 Committee responds to article: “Impact of SARS-CoV-2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients with Coronavirus Disease 2019”.
Digital Pathology
- Remote Sign-Out of Cases With Digital Pathology FAQ
 Addressing the important questions about remote sign-out of cases.
- COVID19 - Remote Sign-Out Guidance White Paper
 Providing guidance related to remote sign-out of cases.
Autopsy
- COVID-19 Autopsy Guideline Statement
 Guidance and services for COVID-19 autopsies that will ultimately guide therapy and assist those engaged in direct patient care.
- COVID-19 Fee-for-Service Autopsy List
 A list of CAP members who expressed an interest in performing autopsies on a fee-for- service basis.
Transfusion, Apheresis and Cellular Therapy
- Information on Concerns for the National Blood Supply
 Considerations for hospital transfusion services.
Cytopathology
- Cytopathology Laboratory Considerations During the COVID-19 Pandemic
 Guidance that applies to cytopathology techniques and specimen processing.
Informatics
- COVID-19 Laboratory Reporting FAQs
 The Informatics and Pathology Electronic Reporting (PERT) Committees offer answers to questions related to reporting requirements for COVID-19 results for molecular, antibody, and antigen tests.
- Resources for Your Practice During the COVID-19 Pandemic
 Curated informatics resources helpful to your practice during the COVID-19 pandemic.